4.6 Article

Esrrb is a cell-cycle-dependent associated factor balancing pluripotency and XEN differentiation

期刊

STEM CELL REPORTS
卷 17, 期 6, 页码 1334-1350

出版社

CELL PRESS
DOI: 10.1016/j.stemcr.2022.04.016

关键词

-

资金

  1. European Research Council (ERC) [715260]
  2. Israeli Center of Research Excellence (I-CORE) program
  3. Israel Science Foundation (ISF) [1618/16]
  4. Azriely Foundation Scholar Program for Distinguished Junior Faculty
  5. European Union [765966]
  6. European Research Council (ERC) [715260] Funding Source: European Research Council (ERC)
  7. Marie Curie Actions (MSCA) [765966] Funding Source: Marie Curie Actions (MSCA)

向作者/读者索取更多资源

This study reveals the relationship between Esrrb and differentiation of embryonic stem cells, and identifies Esrrb as a driver of extraembryonic endoderm cell differentiation during the G2/M phase.
Cell cycle and differentiation decisions are linked; however, the underlying principles that drive these decisions are unclear. Here, we combined cell-cycle reporter system and single-cell RNA sequencing (scRNA-seq) profiling to study the transcriptomes of embryonic stem cells (ESCs) in the context of cell-cycle states and differentiation. By applying retinoic acid, to G1 and G2/M ESCs, we show that, while both populations can differentiate toward epiblast stem cells (EpiSCs), only G2/M ESCs could differentiate into extraembryonic endoderm cells. We identified Esrrb, a pluripotency factor that is upregulated during G2/M, as a driver of extraembryonic endoderm stem cell (XEN) differentiation. Furthermore, enhancer chromatin states based on wild-type (WT) and ESRRB knockout (KO) ESCs show association of ESRRB with XEN poised enhancers. G1 cells overexpressing Esrrb allow ESCs to produce XENs, while ESRRB-KO ESCs lost their potential to differentiate into XEN. Overall, this study reveals a vital link between Esrrb and cell-cycle states during the exit from pluripotency.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据